2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Kaneq Bioscience Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus KQ-791, Placebo - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Kaneq Bioscience Limited | 81 | 2015-06-01 | 2019-11-26 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791 KQ-791, KQ-791 (after meal), Placebo - Healthy Volunteers, Insulin Resistance | Phase 1 | Completed | Kaneq Bioscience Limited | 19 | 2015-02-01 | 2019-11-26 |
Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1)
Canada (1) · United States (1)